The relationship between genetic profiling, clinicopathological factors and survival in patients undergoing surgery for node-negative colorectal cancer: 10-year follow-up

Journal of Cancer Research and Clinical Oncology

Volumn 139, Issue 12, 2013, Pages 2013-2020

  Powell, Arfon G M T ^a   Ferguson, Jenny ^a   Al Mulla, Fahd ^b   Orange, Clare ^a   McMillan, Donald C ^a   Horgan, Paul G ^a   Edwards, Joanne ^a   Going, James J ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Colorectal cancer; Curative surgery; Genetic profiling; Survival

Indexed keywords

ADULT; AGED; ALLELIC IMBALANCE; ARTICLE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER SPECIFIC SURVIVAL; CANCER SURVIVAL; CHROMOSOME 4P; CHROMOSOME 5Q; CLINICAL ARTICLE; CLINICAL FEATURE; COLON RESECTION; COLORECTAL CANCER; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; FOLLOW UP; GENE DELETION; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; PREDICTION; PRIORITY JOURNAL; RECTUM RESECTION; SCORING SYSTEM; TUMOR INVASION; TUMOR VOLUME;

ADULT; AGED; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; GENOMIC INSTABILITY; HUMANS; LYMPH NODES; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; PROGNOSIS; RISK FACTORS; SURVIVAL ANALYSIS; TRANSCRIPTOME;

EID: 84888402703     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-013-1521-2     Document Type: Article

References (22)

1. Al-Mulla F, Behbehani AI, Bitar MS, Varadharaj G, Going JJ (2006) Genetic profiling of stage I and II colorectal cancer may predict metastatic relapse. Mod Pathol 19:648-658
2. Arribas R, Ribas M, Risques RA, Masramon L, Tórtola S, Marcuello E, Aiza G, Miró R, Capellà G, Peinado MA (1999) Prospective assessment of allelic losses at 4p14-16 in colorectal cancer: two mutational patterns and a locus associated with poorer survival. Clin Cancer Res 5:3454-3459
3. Bardia A, Loprinzi C, Grothey A, Nelson G, Alberts S, Menon S, Thome S, Gill S, Sargent D (2010) Adjuvant chemotherapy for resected stage II and III colon cancer: comparison of two widely used prognostic calculators. Semin Oncol 37:39-46
4. Benson AB III (2007) New approaches to assessing and treating early-stage colon and rectal cancers: cooperative group strategies for assessing optimal approaches in early-stage disease. Clin Cancer Res 13(22 Pt 2):6913s-6920s
5. Benson AB III, Schrag D, Somerfield MR, Cohen AM, Figueredo AT, Flynn PJ, Krzyzanowska MK, Maroun J, McAllister P, Van Cutsem E, Brouwers M, Charette M, Haller DG (2004) American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol 22:3408-3419
6. Boelens MC, Kok K, van der Viles P, van der Viles G, Sietsma H, Timens W, Postma DS, Groen HJ, van der Berg A (2009) Genomic Aberrations in Squamous Cell Lung Carcinoma Related to Lymph Node or Distant Metastases. Lung Cancer 66:372-378
7. Cancer Stats (2009) CancerResearchUK.org [homepage on the internet] London: Cancer Research UK; [Page last updated: 17 November 2008; cited April 2009]; Available from: http://info.cancerresearchuk.org/cancerstats/types/bowel/ incidence/
8. Klintrup K, Mäkinen JM, Kauppila S, Väre PO, Melkko J, Tuominen H, Tuppurainen K, Mäkelä J, Karttunen TJ, Mäkinen MJ (2005) Inflammation and prognosis in colorectal cancer. Eur J Cancer 41:2645-2654
9. McMillan DC, McArdle CS, Morrison DS (2010) A clinical risk score to predict 3-, 5- and 10-year survival in patients undergoing surgery for Dukes' A colorectal cancer. Br J Cancer 103:970-974
10. NCBI (2012) FGFRL1 fibroblast growth factor receptor-like 1 [Homo sapiens] http://www.ncbi.nlm.nih.gov/gene/53834
11. Newton KF, Newman W, Hill J (2012) Review of biomarkers in colorectal cancer. Colorectal Dis 14(1):3-17
12. Ott K, Vogelsang H, Mueller J, Becker K, Müller M, Fink U, Siewert JR, Höfler H, Keller G (2003) Chromosomal instability rather than p53 mutation is associated with response to neoadjuvant cisplatin-based chemotherapy in gastric carcinoma. Clin Cancer Res 9:2307-2315
13. Pangon L, Sigglekow ND, Larance M, Al-Sohaily S, Mladenova DN, Selinger CI, Musgrove EA, Kohonen-Corish MR (2010) The "Mutated in Colorectal Cancer" protein is a novel target of the UV-induced DNA damage checkpoint. Genes Cancer 1:917-926
14. Parada LA, Marañon A, Hallén M, Tranberg KG, Stenram U, Bardi G, Johansson B (1999) Cytogenetic analyses of secondary liver tumors reveal significant differences in genomic imbalances between primary and metastatic colon carcinomas. Clin Exp Metastasis 17:471-479
15. Richter J, Wagner U, Schraml P, Maurer R, Alund G, Knönagel H, Moch H, Mihatsch MJ, Gasser TC, Sauter G (1999) Chromosomal imbalances are associated with a high risk of progression in early invasive (pT1) urinary bladder cancer. Cancer Res 59:5687-5691
16. Rödel C, Grabenbauer GG, Papadopoulos T, Bigalke M, Günther K, Schick C, Peters A, Sauer R, Rödel F (2002) Apoptosis as a cellular predictor for histopathologic response to neoadjuvant radiochemotherapy in patients with rectal cancer. Int J Radiat Oncol Biol Phys 52:294-303
17. Roxburgh CS, Salmond JM, Horgan PG, Oien KA, McMillan DC (2009) Comparison of the prognostic value of inflammation-based pathologic and biochemical criteria in patients undergoing potentially curative resection for colorectal cancer. Ann Surg 249:788-793
18. Roxburgh CS, McMillan DC, Anderson JH, McKee RF, Horgan PG, Foulis AK (2010) Elastica staining for venous invasion results in superior prediction of cancer-specific survival in colorectal cancer. Ann Surg 252:989-997
19. Sheffer M, Bacolod MD, Zuk O, Giardina SF, Pincas H, Barany F, Paty PB, Gerald WL, Notterman DA, Domany E (2008) Association of survival and disease progression with chromosomal instability: a genomic exploration of colorectal cancer. PNAS 106:7131-7136
20. Söreide K, Janssen EA, Söiland H, Körner H, Baak JP (2006) Microsatellite instability in colorectal cancer. Br J Surg 93:395-406
21. Starr TK, Allaei R, Silverstein KAT, Staggs RA, Sarver AL, Bergemann TL, Gupta M, O'Sullivan MG, Matise I, Dupuy AJ, Collier LS, Powers S, Oberg AL, Asmann YW, Thibodeau SN, Tessarollo L, Copeland NG, Jenkins NA, Cormier RT, Largaespada DA (2009) A transposon-based genetic screen in mice identifies genes altered in colorectal cancer. Science 323:1747-1750
22. Zhang F, Zhou C, Ling Y, Qiu G, Bai S, Liu W, He L, Peng Z (2002) Allelic analysis on chromosome 5 in sporadic colorectal cancer patients. Zhonghua Zhong Liu Za Zhi 24(5):458-460